Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

P. Mulani · SciRah

Researcher profile · Semantic Scholar

P. Mulani

Share profile

P. Mulani — researcher profile on SciRah

h-index: 39
Works: 251
Citations: 6,105

Most-cited papers

Adalimumab for the Treatment of Moderate to Severe Hidradenitis Suppurativa
A. Kimball, F. Kerdel, D. Adams, U. Mrowietz +12 more
2012Annals of Internal Medicine423 citations
Semantic Scholar
Comparative Effectiveness Without Head-to-Head Trials
J. Signorovitch, E. Wu, A. Yu, C. Gerrits +4 more
2012PharmacoEconomics (Auckland)372 citations
Semantic Scholar
Adalimumab induces deep remission in patients with Crohn's disease.
J. Colombel, P. Rutgeerts, W. Sandborn, Mei Yang +7 more
2014Clinical Gastroenterology and Hepatology247 citations
Semantic Scholar
Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment
A. Kimball, G. Jemec, Min Yang, Andrew Kageleiry +6 more
2014British Journal of Dermatology204 citations Open access
Semantic Scholar
Risks of developing psychiatric disorders in pediatric patients with psoriasis.
A. Kimball, E. Wu, A. Guerin, A. Yu +4 more
2012Journal of American Academy of Dermatology187 citations
Semantic Scholar
Cardiovascular event risk assessment in psoriasis patients treated with tumor necrosis factor‐&agr; inhibitors versus methotrexate
Jashin J. Wu, A. Guerin, M. Sundaram, K. Dea +2 more
2017Journal of American Academy of Dermatology124 citations
Semantic Scholar
Adalimumab therapy is associated with reduced risk of hospitalization in patients with ulcerative colitis.
B. Feagan, W. Sandborn, A. Lazar, R. Thakkar +7 more
2014Gastroenterology107 citations Open access
Semantic Scholar
Increased risk of venous thromboembolic events with corticosteroid vs biologic therapy for inflammatory bowel disease.
P. Higgins, M. Skup, P. Mulani, Jay Lin +1 more
2015Clinical Gastroenterology and Hepatology101 citations
Semantic Scholar
Dosage adjustment during long‐term adalimumab treatment for Crohn's disease: Clinical efficacy and pharmacoeconomics
W. Sandborn, J. Colombel, S. Schreiber, S. Plevy +4 more
2011Inflammatory Bowel Diseases83 citations
Semantic Scholar
The effects of adalimumab treatment and psoriasis severity on self-reported work productivity and activity impairment for patients with moderate to severe psoriasis.
A. Kimball, A. Yu, J. Signorovitch, Jipan Xie +4 more
2012Journal of American Academy of Dermatology78 citations
Semantic Scholar
Efficacy and safety of adalimumab in Canadian patients with moderate to severe Crohn's disease: results of the Adalimumab in Canadian SubjeCts with ModErate to Severe Crohn's DiseaSe (ACCESS) trial.
R. Panaccione, E. Loftus, D. Binion, K. Mchugh +5 more
2011Canadian journal of gastroenterology = Journal canadien de gastroenterologie78 citations Open access
Semantic Scholar
Comparative efficacy of biological treatments for moderate‐to‐severe psoriasis: a network meta‐analysis adjusting for cross‐trial differences in reference arm response
J. Signorovitch, Keith A. Betts, Y.-S. Yan, C. Lereun +3 more
2015British Journal of Dermatology68 citations
Semantic Scholar
Cost Per Responder Associated with Biologic Therapies for Crohn’s Disease, Psoriasis, and Rheumatoid Arthritis
Yifei Liu, E. Wu, A. Bensimon, C. Fan +5 more
2012Advances in Therapy61 citations Open access
Semantic Scholar
Sleep quality and other patient‐reported outcomes improve after patients with psoriasis with suboptimal response to other systemic therapies are switched to adalimumab: results from PROGRESS, an open‐label Phase IIIB trial
Bruce E. Strober, J. Sobell, K. Duffin, Y. Bao +5 more
2012British Journal of Dermatology61 citations
Semantic Scholar
Psoriasis and risk of diabetes-associated microvascular and macrovascular complications.
A. Armstrong, A. Guerin, M. Sundaram, E. Wu +3 more
2015Journal of American Academy of Dermatology58 citations
Semantic Scholar
Adalimumab improves patient-reported outcomes and reduces indirect costs in patients with moderate to severe Crohn's disease: results from the CARE trial.
E. Louis, R. Löfberg, W. Reinisch, A. Camez +5 more
2013Journal of Crohn's & Colitis55 citations Open access
Semantic Scholar
Efficacy and Safety of Adalimumab among Patients with Moderate to Severe Psoriasis with Co-Morbidities
A. Kimball, A. Bensimon, A. Guerin, A. Yu +5 more
2011American Journal of Clinical Dermatology55 citations
Semantic Scholar
Efficacy, safety and medication cost implications of adalimumab 40 mg weekly dosing in patients with psoriasis with suboptimal response to 40 mg every other week dosing: results from an open‐label study
C. Leonardi, J. Sobell, Jeffrey J. Crowley, U. Mrowietz +4 more
2012British Journal of Dermatology50 citations
Semantic Scholar
Cost Utility of Adalimumab versus Infliximab Maintenance Therapies in the United States for Moderately to Severely Active Crohn’s Disease
A. Yu, Scott J. Johnson, Si-Tien Wang, P. Atanasov +4 more
2012PharmacoEconomics (Auckland)45 citations
Semantic Scholar
Longer durations of antitumour necrosis factor treatment are associated with reduced risk of cardiovascular events in patients with rheumatoid arthritis
M. Nurmohamed, Y. Bao, J. Signorovitch, Alex Trahey +2 more
2015RMD Open43 citations Open access
Semantic Scholar
Effect of adalimumab on work productivity and indirect costs in moderate to severe Crohn's disease: a meta-analysis.
D. Binion, E. Louis, B. Oldenburg, P. Mulani +3 more
2011Canadian journal of gastroenterology = Journal canadien de gastroenterologie39 citations Open access
Semantic Scholar
Qualitative assessment of the content validity of the Dermatology Life Quality Index in patients with moderate to severe psoriasis
S. Safikhani, M. Sundaram, Y. Bao, P. Mulani +1 more
2013Journal of dermatological treatment (Print)38 citations
Semantic Scholar
Effect of adalimumab on clinical laboratory parameters in patients with Crohn's disease: Results from the CHARM trial
D. Rubin, P. Mulani, J. Chao, P. Pollack +3 more
2012Inflammatory Bowel Diseases36 citations
Semantic Scholar
Comprehensive disease control (CDC): what does achieving CDC mean for patients with rheumatoid arthritis?
P. Emery, A. Kavanaugh, Y. Bao, A. Ganguli +1 more
2014Annals of the Rheumatic Diseases35 citations Open access
Semantic Scholar
Psoriasis patients’ willingness to accept side-effect risks for improved treatment efficacy
T. Kauf, Jui-Chen Yang, A. Kimball, M. Sundaram +5 more
2015Journal of dermatological treatment (Print)27 citations
Semantic Scholar
Effects of briakinumab treatment for moderate to severe psoriasis on health‐related quality of life and work productivity and activity impairment: results from a randomized phase III study
K. Papp, M. Sundaram, Y. Bao, David A. Williams +5 more
2014Journal of the European Academy of Dermatology and Venereology27 citations
Semantic Scholar
Effects of Adalimumab versus Placebo on Risk of Symptom Worsening in Psoriasis and Subsequent Impacts on Health-Related Quality-of-Life
K. Papp, J. Signorovitch, K. Ramakrishnan, A. Yu +3 more
2011Clinical drug investigation12 citations
Semantic Scholar
Nomenclature and Traceability Debate for Biosimilars: Small-Molecule Surrogates Lend Support for Distinguishable Nonproprietary Names
J. Chao, M. Skup, Emily Alexander, N. Tundia +3 more
2015Advances in Therapy9 citations Open access
Semantic Scholar
The Impact of Moderate-to-severe Crohn's Disease on Employees' Salary Growth
E. Loftus, M. Skup, A. B. Ozbay, E. Wu +3 more
2014Inflammatory Bowel Diseases6 citations
Semantic Scholar
AB1395 Switching from adalimumab to other disease-modifying antirheumatic drugs without apparent medical reasons in rheumatoid arthritis: Impact on health care service use
J. Signorovitch, Y. Bao, T. Samuelson, P. Mulani
20135 citations
Semantic Scholar
P285 Complications associated with colectomy in patients with ulcerative colitis
P. Leonard, M. Yang, J. Chao, P. Mulani
20125 citations Open access
Semantic Scholar
Adalimumab Induction Dose Reduces the Risk of Hospitalizations and Colectomies in Patients with Ulcerative Colitis During the First 8 Weeks of Therapy: 1601
B. Feagan, W. Sandborn, A. Lazar, R. Thakkar +4 more
20125 citations
Semantic Scholar
1099 A Retrospective Study of Colectomy Complications and Their Associated Costs for Patients With Ulcerative Colitis
E. Loftus, P. Leonard, Mei Yang, Oscar Hayes +2 more
20125 citations Open access
Semantic Scholar
Cost-Effectiveness of Adalimumab in Moderately to Severely Active Ulcerative Colitis: 1588
T. Ali, M. Skup, Mei Yang, Min Yang +3 more
20124 citations
Semantic Scholar
Rapid onset of adalimumab and long-term efficacy among week-8 responders in adults with moderate to severe active Ulcerative Colitis: O-7.
W. Sandborn, D. Wolf, G. Van Assche, Mei Yang +5 more
20114 citations Open access
Semantic Scholar
Sustained Clinical Remission of Ulcerative Colitis is Associated with Greater Improvements in Quality of Life, Work Productivity and Activity: 1210
W. Sandborn, J. Colombel, Mei Yang, R. Thakkar +2 more
20114 citations
Semantic Scholar
PTU-059 Adalimumab Therapy Reduces Hospitalization and Colectomy Rates in Patients with Ulcerative Colitis among Initial Responders
B. Feagan, W. Sandborn, Martha Skup, M. Yang +4 more
2013Gut3 citations Open access
Semantic Scholar
Time-In-Remission Analysis of Adalimumab vs. Placebo for the Treatment of Ulcerative Colitis: 1590
W. Sandborn, R. Thakkar, A. Lazar, M. Skup +4 more
20123 citations
Semantic Scholar
P257 Importance of deep remission compared with mucosal healing only: Results from EXTEND
W. Sandborn, J. Colombel, R. Panaccione, E. Louis +6 more
20123 citations Open access
Semantic Scholar
Adalimumab Therapy Reduces Hospitalization and Colectomy Rates in Patients with Ulcerative Colitis Among Initial Responders: 1592
B. Feagan, W. Sandborn, Mei Yang, M. Skup +4 more
20123 citations
Semantic Scholar
P223 Improved work productivity in caregivers of pediatric patients with Crohn's disease treated with adalimumab
F. Ruemmele, W. Crandall, J. Escher, G. Veereman-Wauters +7 more
20132 citations Open access
Semantic Scholar
Association between Adherence to Adalimumab Therapy and Health Care Costs for Patients with Crohnʼs Disease: Claims Database Analysis: 1708
Bradley Schifrien, Eugene F. Yen, Yifei Liu, M. Skup +6 more
20132 citations
Semantic Scholar
FRI0145 The effect of adalimumab on risk of major adverse cardiovascular events in rheumatoid arthritis: A meta-analysis of randomized trials
Gerd R. Burmester, P. Emery, J. Signorovitch, David A. Williams +3 more
20132 citations
Semantic Scholar
OP05 Development of three practical indices for mucosal healing among patients with moderate to severe Crohn's disease
W. Sandborn, R. Panaccione, J. Colombel, E. Louis +4 more
20122 citations Open access
Semantic Scholar
PWE-254 Impact of induction dosing on maintenance outcome with adalimumab in Crohn's disease
J. Colombel, P. Rutgeerts, W. Sandborn, W. Reinisch +8 more
2012Gut2 citations Open access
Semantic Scholar
Su1019 Complications Associated With Colectomy in Patients With Ulcerative Colitis
P. Leonard, Mei Yang, J. Chao, P. Mulani
20122 citations
Semantic Scholar
Comparative Colorectal Cancer Risk in Patients with Ulcerative Colitis Treated with Adalimumab Versus Conventional Therapy: 1598
J. Colombel, R. Thakkar, A. Robinson, Mei Yang +5 more
20122 citations
Semantic Scholar
Markov model projection of remission status for early versus delayed step-up adalimumab use in moderate to severe crohn's disease
E. Loftus, J. Chao, M. Yang, P. Pollack +3 more
2011Gut2 citations Open access
Semantic Scholar
Risk of Leaving the Workforce in Non-infectious Uveitis
N. Tundia, M. Skup, R. Sorg, D. Macaulay +3 more
20141 citations
Semantic Scholar
Direct and Indirect Resource Use and Costs Associated With Non-Infectious Non-Anterior Uveitis
J. Thorne, N. Tundia, M. Skup, D. Macaulay +4 more
20141 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Chao×30
Invite
J. Chao — researcher profile on SciRah
Y. Bao×16
Invite
Y. Bao — researcher profile on SciRah
Mei Yang×16
Invite
Mei Yang — researcher profile on SciRah
R. Thakkar×13
Invite
R. Thakkar — researcher profile on SciRah

×13

Invite

M. Skup — researcher profile on SciRah

J. Signorovitch×9

Invite

J. Signorovitch — researcher profile on SciRah

Invite

E. Wu — researcher profile on SciRah

Invite

W. Sandborn — researcher profile on SciRah

Invite

A. Yu — researcher profile on SciRah

Invite

P. Pollack — researcher profile on SciRah

Invite

A. Lazar — researcher profile on SciRah

Invite

A. Kimball — researcher profile on SciRah